Document is current

Article History

Received: 9 December 2024

Accepted: 14 February 2025

First Online: 9 April 2025

Declarations

:

: Sofia Ramiro has received research grants from AbbVie, Galapagos/Alfasigma, Merck Sharp & Dohme, Novartis, Pfizer, UCB; consulting and/or speaker fees from AbbVie, Eli Lilly and Company, Galapagos/Alfasigma, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Sanofi, UCB; ASAS Executive Committee member. Georg Schett has received speaker honoraria from Bristol Myers Squibb, Cabaletta, Janssen, Kyverna, Miltenyi, and Novartis. Helena Marzo-Ortega has received research grants from Janssen, Novartis, Pfizer, UCB; honoraria/consultation fees: AbbVie, Amgen, Biogen, Eli Lilly, Janssen, Moonlake, Novartis, Pfizer, Takeda, UCB; trial participation as principal investigator for AbbVie, Biogen, Eli Lilly, Janssen, Novartis, Pfizer, UCB. She is supported by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the (UK) National Health Service (NHS), the NIHR, or the (UK) Department of Health. Wolfgang A. Schmidt has received speaker honoraria from AbbVie, Amgen, Bristol Myers Squibb, Chugai, GlaxoSmithKline, Johnson & Johnson, Medac, Novartis, Roche, UCB; advisory board honoraria from AbbVie, Amgen, Boehringer Ingelheim, Fresenius Kabi, GlaxoSmithKline, Novartis, Sanofi; trial participation as principal investigator for AbbVie, GlaxoSmithKline, Novartis, Sanofi. At the time of publication, his affiliation is Krankenhaus Waldfriede, Rheumatology, Berlin, Germany.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.